Virologic Response, Early HIV-1 Decay, and Maraviroc Pharmacokinetics With the Nucleos(t)ide-Free Regimen of MaravIroc Plus Darunavir/Ritonavir in a Pilot Study
暂无分享,去创建一个
D. Kuritzkes | S. Swindells | J. Castro | O. Adeyemi | E. Acosta | Patrick A Ryscavage | B. Taiwo | B. Berzins | A. Tsibris | J. Eron | J. Lalezari | Darlene Lu | Athe Tsibris